Bioextrax AB (85X0) Stock Statistics & Valuation Metrics

Bioextrax AB has a market cap or net worth of €11.44M. The enterprise value is €48.45M.

Bioextrax AB has 39,729,134 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bioextrax AB’s return on equity (ROE) is -0.67 and return on invested capital (ROIC) is -76.01%.

The current PE Ratio of Bioextrax AB is -7.00. Bioextrax AB’s PEG ratio is -0.05.

In the last 12 months, Bioextrax AB had revenue of 515.00K and earned -17.34M in profits. Earnings per share was -0.52.

In the last 12 months, operating cash flow was -18.78M and capital expenditures -215.00K, giving a free cash flow of -18.99M billion.

Bioextrax AB pays an annual dividend of ―, resulting in a dividend yield of ―

Bioextrax AB upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.

Bioextrax AB as a current ratio of 6.54, with Debt / Equity ratio of 0.00%

In the past 12 months, Bioextrax AB has paid 0.00 in taxes.

Bioextrax AB EV to EBITDA ratio is -6.43, with an EV/FCF ratio of -5.48.

Bioextrax AB has €17.27M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€17.27M billion.

Gross margin is -4718.23%, with operating margin of -3405.63%, and net profit margin of -3366.60%.

The average price target for Bioextrax AB is ―, which is 11.43% higher than the current price. The consensus rating is ―